Enzyme was founded with the mission to streamline regulatory approval and compliance processes for life science companies. Their core vision is to simplify the path to FDA approval and ensure ongoing compliance through innovative solutions. Enzyme offers a cloud-based Quality Management System (QMS) that is 21 CFR Part 11 compliant and validated out-of-the-box. Their platform includes modules for document control, change control, training, premarket design control, risk management, supplier management, postmarket audits, complaints, nonconformance, and CAPA (Corrective and Preventive Actions). Enzyme also provides supportive QA/RA consulting services, leveraging over 50 years of combined experience in the medical device industry.

Notable figures affiliated with Enzyme include seasoned professionals from Fortune 500 companies and startups, bringing extensive expertise to the table. The company has secured significant investments from industry-leading venture capital firms, underscoring its potential and credibility. Key achievements include the successful implementation of their QMS in numerous life science companies, facilitating faster FDA approvals and ensuring robust compliance. Enzyme's impact is evident in its ability to help companies scale efficiently while maintaining stringent regulatory standards, positioning it as a pivotal player in the life sciences regulatory landscape.